---
title: "LFCR股票警報：Halper Sadeh LLC正在調查Lifecore Biomedical, Inc.是否為其股東獲得了公平價格"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/300327853.md"
description: "Halper Sadeh LLC 正在調查 Lifecore Biomedical, Inc.在以每股 6.28 美元外加或有價值權出售給 Webster Equity Partners 的交易中，是否為其股東獲得了公平價格。該律所指控董事會可能存在違反信義義務和證券法的行為，具體涉及銷售流程和信息披露。鼓勵股東聯繫該律所以討論其權利"
datetime: "2026-09-28T15:52:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300327853.md)
  - [en](https://longbridge.com/en/news/300327853.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300327853.md)
generator: "portal-rs"
---

# LFCR股票警報：Halper Sadeh LLC正在調查Lifecore Biomedical, Inc.是否為其股東獲得了公平價格

**LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders**

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.*** 

***The proposed transaction may contain terms that could limit superior competing offers.*** 

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.* *We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.*** 

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lifecore Biomedical, Inc. (NASDAQ: LFCR) to Webster Equity Partners for $6.28 per share in cash plus one non-tradable contingent value right per share. 

Halper Sadeh encourages Lifecore shareholders to **click here to learn more about their rights and options**or contact Daniel Sadeh or Zachary Halper **free of charge** at (212) 763-0060 or **sadeh@halpersadeh.com** or **zhalper@halpersadeh.com**. 

The investigation concerns whether Lifecore and its board of directors violated the federal securities laws and/or breached their fiduciary duties by failing to: (1) obtain the best possible price for Lifecore shareholders; (2) conduct a fair sales process free of any conflicts of interests; and (3) disclose all material information for Lifecore shareholders to evaluate the transaction. 

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits. 

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. 

Attorney Advertising. Prior results do not guarantee a similar outcome. 

Halper Sadeh LLC  
One World Trade Center  
85th Floor  
New York, NY 10007  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
(212) 763-0060  
sadeh@halpersadeh.com  
zhalper@halpersadeh.com  
https://www.halpersadeh.com 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260928295713/en/

### 相關股票

- [LFCR.US](https://longbridge.com/zh-HK/quote/LFCR.US.md)

## 相關資訊與研究

- [Lifecore Biomedical, Inc. (NASDAQ:LFCR) 獲分析師平均“減持”評級](https://longbridge.com/zh-HK/news/300570979.md)
- [LFCR股東警報：Ademi LLP調查收購案是否對Lifecore Biomedical, Inc.進行了公允估值](https://longbridge.com/zh-HK/news/300330454.md)
- [Lifecore Biomedical旗下單位Lifecore Biomedical LLC將與愛爾康的製造協議期限延長至2034年](https://longbridge.com/zh-HK/news/300479928.md)
- [交易快報：荷美爾食品收購Brakebush，安森美以57億美元收購Synaptics，Leslie’s Pools申請破產](https://longbridge.com/zh-HK/news/300816626.md)
- [LFCR、ITGR、FHB、INDV 是否為其股東爭取到了公平的交易？](https://longbridge.com/zh-HK/news/300470630.md)

---
> **免責聲明: 本文僅供參考，不構成任何投資建議。**